Cathay Health
Investor profile
Venture capital
Cathay Health has backed 3 European tech companies across 4 funding rounds between 2022 and 2023, joining rounds totalling €152M. Most active in Healthtech and Robotics. Data as of Nov 2026.
Deals
4
distinct rounds
Companies
3
backed
Active span
2022–2023
2 yrs
Total round €
€152M
sum of rounds joined
Deals by year
distinct rounds / yearCathay Health — deals by year — interactive chart.
Data table
| Cathay Health — deals by year | |
|---|---|
| 2022 | 2 |
| 2023 | 2 |
Top sectors
by dealsCathay Health — top sectors — interactive chart.
Data table
| Cathay Health — top sectors | |
|---|---|
| Healthtech | 3 |
| Robotics | 1 |
Stages
by dealsCathay Health — stages — interactive chart.
Data table
| Cathay Health — stages | |
|---|---|
| Other | 1 |
| Series A | 1 |
| Series B | 1 |
| Series D+ | 1 |
Countries
by dealsCathay Health — countries — interactive chart.
Data table
| Cathay Health — countries | |
|---|---|
| France | 4 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Sofinnova Partners3
- Crédit Mutuel Innovation2
- GT Healthcare Capital & Partners2
- Richard Leparmentier2
- Sacha Loiseau2
- Siddarth Satish2
- Yann Fleureau2
- BNP Paribas Développement1
- Fonds Stratégique des Transitions1
- Fred Moll1
- Johnson & Johnson Innovation1
- Johnson & Johnson Innovation – JJDC1
- Josh Makower1
- Kurma Partners1
- MD Start1
- Merieux Developpement1
- NVentures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Moon Surgical | France | 2 | €81M |
| Tissium | France | 1 | €50M |
| Ganymed Robotics | France | 1 | €21M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Moon Surgical | Other | €51M | 2023-05 |
| Tissium | Series D+ | €50M | 2023-05 |
| Moon Surgical | Series A | €30M | 2022-06 |
| Ganymed Robotics | Series B | €21M | 2022-07 |